Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikos Maniadakis

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 24, 2011
Quality of life measurement in patients with hypertension in CyprusMamas Theodorou, Daphne Kaitelidou, Petros Galanis, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2011
Atrial fibrillation ablation: a cost or an investment?Josef Kautzner, Veronika Bulkova, Gerhard Hindricks, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 20, 2020
Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in GreeceGeorgia Kourlaba, Garyfallia Stefanou, Sotiris Tsalamandris, et al.
BMC Health Services Research|August 5, 2015
Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation studyGeorgia Kourlaba, Vasiliki Rapti, Athanasios Alexopoulos, et al.
Advances in Therapy|August 6, 2018
A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and ConsequencesNikos Maniadakis, Emese Toth, Michael Schiff, et al.
Clinical Drug Investigation|June 14, 2017
Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in GreeceGeorge Gourzoulidis, Georgia Kourlaba, John Kakisis, et al.
Vaccines|June 25, 2026
Attitudes, Motivation, and Predictors of Influenza Vaccination Uptake Among Primary Healthcare Professionals in GreeceIsidoros Kougioumtzoglou, Evangelia-Georgia Kostaki, George Soulis, et al.
Cost Effectiveness and Resource Allocation : C/E|July 16, 2021
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectivesZoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, et al.
Cost Effectiveness and Resource Allocation : C/E|September 1, 2021
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findingsZsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2014
Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancerGeorgia Kourlaba, Meletios A Dimopoulos, Dimitrios Pectasides, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 24, 2011
Quality of life measurement in patients with hypertension in CyprusMamas Theodorou, Daphne Kaitelidou, Petros Galanis, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 27, 2011
Atrial fibrillation ablation: a cost or an investment?Josef Kautzner, Veronika Bulkova, Gerhard Hindricks, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 20, 2020
Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in GreeceGeorgia Kourlaba, Garyfallia Stefanou, Sotiris Tsalamandris, et al.
BMC Health Services Research|August 5, 2015
Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation studyGeorgia Kourlaba, Vasiliki Rapti, Athanasios Alexopoulos, et al.
Advances in Therapy|August 6, 2018
A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and ConsequencesNikos Maniadakis, Emese Toth, Michael Schiff, et al.
Clinical Drug Investigation|June 14, 2017
Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in GreeceGeorge Gourzoulidis, Georgia Kourlaba, John Kakisis, et al.
Vaccines|June 25, 2026
Attitudes, Motivation, and Predictors of Influenza Vaccination Uptake Among Primary Healthcare Professionals in GreeceIsidoros Kougioumtzoglou, Evangelia-Georgia Kostaki, George Soulis, et al.
Cost Effectiveness and Resource Allocation : C/E|July 16, 2021
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectivesZoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, et al.
Cost Effectiveness and Resource Allocation : C/E|September 1, 2021
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findingsZsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2014
Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancerGeorgia Kourlaba, Meletios A Dimopoulos, Dimitrios Pectasides, et al.
Pageof 7